Caprock Group’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
Caprock Group's GH Position: Q2 2026 in Review
Caprock Group reduced its Guardant Health (GH) stake by 20% in Q2 2026, selling an estimated $186K and leaving 7,057 shares worth $1.06M. The position accounts for 0.02% of the portfolio, ranked #613.
Caprock Group first reported a position in GH in Q1 2025 and has held it in 5 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Caprock Group held 7,057 shares of Guardant Health worth $1.06M as of Q2 2026.
- Caprock Group sold 1,714 Guardant Health shares in Q2 2026, an estimated $186K.
- Guardant Health made up 0.02% of Caprock Group's portfolio in Q2 2026, its #613 holding.
- Caprock Group first reported a position in Guardant Health in Q1 2025 and has held it in 5 quarters since.
- 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.